Biotech · Private company
Swedish Orphan Biovitrum
Track this companyFree. Adds Swedish Orphan Biovitrum to your Dealase workspace and tells you when its record changes.
Clinical trials2510 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline19
- EmapalumabPhase 3 · Primary Hemophagocytic LymphohistiocytosisClinicalTrials.gov · fetched Nov 12, 2026
- EmapalumabPhase 3 · Macrophage Activation SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Emapalumab-LzsgPhase 3 · Hemophagocytic LymphohistiocytosesClinicalTrials.gov · fetched Nov 12, 2026
- NI-0501Phase 3 · Primary Haemophagocytic LymphohistiocytosisClinicalTrials.gov · fetched Nov 12, 2026
- PacritinibPhase 3 · Primary MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PegcetacoplanPhase 3 · Cold Agglutinin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Physician's Choice medicationsPhase 3 · Primary MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- SEL-212 high-dosePhase 3 · Chronic GoutClinicalTrials.gov · fetched Nov 12, 2026
- SEL-212 low-dosePhase 3 · Chronic GoutClinicalTrials.gov · fetched Nov 12, 2026
- PacritinibPhase 2 · VEXASClinicalTrials.gov · fetched Nov 12, 2026
- PegcetacoplanPhase 2 · Transplant-Associated Thrombotic MicroangiopathyClinicalTrials.gov · fetched Nov 12, 2026
- Blood DrawsHemophagocytic LymphohistiocytosisClinicalTrials.gov · fetched Nov 12, 2026
- Blood Draws Data CollectionHemophagocytic LymphohistiocytosesClinicalTrials.gov · fetched Nov 12, 2026
- Chart reviewMacrophage Activation SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Data CollectionHemophagocytic LymphohistiocytosisClinicalTrials.gov · fetched Nov 12, 2026
- Local Lab TestsHemophagocytic Lymphohistiocytosis (HLH)ClinicalTrials.gov · fetched Nov 12, 2026
- Local laboratory testingHemophagocytic Lymphohistiocytosis (HLH)ClinicalTrials.gov · fetched Nov 12, 2026
- Not applicable- observational studyMyelofibrosis (MF)ClinicalTrials.gov · fetched Nov 12, 2026
- Recombinant coagulation factor (rFVIIIFc)Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant.NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07909005 · fetched Nov 12, 2026
- Pacritinib Effectiveness in Real-world SettingsRECRUITING · started Aug 13, 2026ClinicalTrials.gov NCT07774455 · fetched Nov 12, 2026
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) StudyPHASE2 · RECRUITING · started Jul 23, 2026ClinicalTrials.gov NCT07486869 · fetched Nov 12, 2026
- Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative NeoplasmsPHASE2 · RECRUITING · started Mar 2, 2026ClinicalTrials.gov NCT07148947 · fetched Nov 12, 2026
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)PHASE2 · RECRUITING · started May 28, 2025ClinicalTrials.gov NCT06782373 · fetched Nov 12, 2026
- Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromePHASE1 · RECRUITING · started Feb 13, 2025ClinicalTrials.gov NCT06538181 · fetched Nov 12, 2026
- Emapalumab Prevention of CAR-T Cell Associated ToxicitiesPHASE2 · RECRUITING · started Sep 18, 2024ClinicalTrials.gov NCT06550141 · fetched Nov 12, 2026
- Avatrombopag vs. Placebo for CIT in GI MalignanciesPHASE2 · COMPLETED · started Nov 1, 2023ClinicalTrials.gov NCT05772546 · fetched Nov 12, 2026
- Assessment of Macrophage Activation syndromE in STill's DiseaseCOMPLETED · started Sep 27, 2023ClinicalTrials.gov NCT06405152 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)PHASE3 · COMPLETED · started Oct 20, 2022ClinicalTrials.gov NCT05096403 · fetched Nov 12, 2026
- A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantationPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05148299 · fetched Nov 12, 2026
- Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell TherapyPHASE2 · COMPLETED · started Dec 27, 2021ClinicalTrials.gov NCT04359784 · fetched Nov 12, 2026
- Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLEPHASE3 · COMPLETED · started Dec 15, 2021ClinicalTrials.gov NCT05001737 · fetched Nov 12, 2026
- A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy IIPHASE3 · COMPLETED · started Nov 30, 2020ClinicalTrials.gov NCT04596540 · fetched Nov 12, 2026
- A Study of SEL-212 in Patients With Gout Refractory to Conventional TherapyPHASE3 · COMPLETED · started Aug 18, 2020ClinicalTrials.gov NCT04513366 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLHPHASE2_PHASE3 · TERMINATED · started Jun 2, 2020ClinicalTrials.gov NCT03985423 · fetched Nov 12, 2026
- Open-label Study of Anakinra in MPS IIIPHASE1_PHASE2 · COMPLETED · started Jan 30, 2020ClinicalTrials.gov NCT04018755 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic LymphohistiocytosisPHASE3 · COMPLETED · started Feb 6, 2019ClinicalTrials.gov NCT03312751 · fetched Nov 12, 2026
- Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear DiseasePHASE2 · RECRUITING · started Jan 3, 2019ClinicalTrials.gov NCT03587701 · fetched Nov 12, 2026
- Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI TherapiesPHASE4 · COMPLETED · started Aug 29, 2017ClinicalTrials.gov NCT03103542 · fetched Nov 12, 2026
- A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia MyelofibrosisPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 26, 2017ClinicalTrials.gov NCT03165734 · fetched Nov 12, 2026
- Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic LymphohistiocytosisCOMPLETED · started Dec 14, 2016ClinicalTrials.gov NCT06047210 · fetched Nov 12, 2026
- Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic LymphohistiocytosisCOMPLETED · started Oct 13, 2016ClinicalTrials.gov NCT03259230 · fetched Nov 12, 2026
- Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic LymphohistiocytosisPHASE2_PHASE3 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01818492 · fetched Nov 12, 2026
- Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell TransplantationPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 1, 2012ClinicalTrials.gov NCT01746849 · fetched Nov 12, 2026